Innovative Fusion Superkine and Focused Ultrasound Offer New Hope for Glioblastoma Treatment
Innovative fusion superkine combined with focused ultrasound offers a promising noninvasive therapy for glioblastoma, targeting tumor cells and boosting immune response through advanced delivery techniques.
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a groundbreaking approach to combat glioblastoma (GBM), one of the most aggressive and deadly brain cancers with no current cure. This innovative strategy combines a novel fusion superkine (FSK), which includes dual therapeutic cytokines, with advanced focused ultrasound technology to deliver the treatment safely across the blood-brain barrier (BBB). The FSK integrates two potent molecules: a next-generation IL-24S (superkine) that induces tumor cell death, and IL-15, which activates important immune cells, enhancing the immune response against cancer cells. In preclinical studies involving glioblastoma models, this combination has demonstrated superior tumor regression and increased survival rates compared to individual cytokines, inspiring hope for more effective treatments.
The delivery method involves creating an adenovirus vector expressing the FSK, which is then transported into the brain using focused ultrasound and microbubbles (FUS-DMB). This technique temporarily and safely opens the BBB, allowing the therapeutic virus to reach tumor sites without invasive surgery—a significant advancement in brain cancer therapy. The researchers aim to expand this approach into clinical trials by 2026, with the goal of providing a noninvasive option for treating primary and secondary brain tumors.
This research marks a significant milestone in immunotherapy and virotherapy fields, addressing the challenges of drug delivery and immune suppression typical of GBM. Experts believe this technology could revolutionize how brain tumors are treated by not only destroying existing tumors but also fostering a long-lasting immune response to prevent recurrence. As the team continues to refine their methods, future studies will explore the potential applications across various tumor types, aiming to ultimately improve patient outcomes worldwide.
Source: https://medicalxpress.com/news/2025-06-fusion-superkine-focused-ultrasound-enable.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Study Finds Toxic Metals Present in All Rice Samples Across U.S. Stores
A new report reveals that all tested rice samples across U.S. stores contain toxic heavy metals, including arsenic, cadmium, lead, and mercury, raising health concerns about rice consumption.
Research Confirms It's 'Never Too Late' to Gain Survival Benefits from Quitting Smoking, Even with Advanced Cancer
New research confirms that quitting smoking can significantly improve survival in cancer patients, even those with late-stage cancer. Learn how cessation can be a vital part of overall treatment and outcome.
Advancing Monitoring and Intervention Strategies for Commercial Determinants of Health
Exploring how regulations and transparency in corporate practices can improve public health by reducing harmful influences, promoting better policy and corporate accountability.
New Prognostic Marker Identified for Advanced Lung Adenocarcinoma
A groundbreaking study identifies perilipin 2 as a key factor in the progression of advanced lung adenocarcinoma, highlighting its potential as a prognostic marker and therapeutic target.